Literature DB >> 20151405

Genetic analysis of von Hippel-Lindau disease.

Morgan Nordstrom-O'Brien1, Rob B van der Luijt, Ellen van Rooijen, Ans M van den Ouweland, Danielle F Majoor-Krakauer, Martijn P Lolkema, Aram van Brussel, Emile E Voest, Rachel H Giles.   

Abstract

Mutations in the von Hippel-Lindau (VHL) gene are responsible for VHL disease, congenital polycythemia, and are found in many sporadic tumor types as well. Reports of VHL mutations are dispersed throughout original articles and databases that have not been recently updated. We compiled a comprehensive mutation table of 1,548 germline and somatic VHL mutations, derived from this protein of only 213 amino acids. We describe detailed phenotype and gene mutation information for 945 VHL families, including 30 previously unpublished kindreds from The Netherlands (six novel mutations). These data represent the most extensive catalog of germline VHL mutations to date. We also review VHL disease, known and theorized pathogenesis of common VHL manifestations, and genotype-phenotype correlations. Analysis of all VHL families, excluding germline mutations resulting in congenital polycythemias, describes the spectrum of mutation types: 52% missense, 13% frameshift, 11% nonsense, 6% in-frame deletions/insertions, 11% large/complete deletions, and 7% splice mutations. This easy-to-use compilation of VHL mutations is intended to facilitate research and function as a necessary adjunct for physicians when providing patient information. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20151405     DOI: 10.1002/humu.21219

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  89 in total

1.  Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.

Authors:  Charline Ladroue; David Hoogewijs; Sophie Gad; Romain Carcenac; Federica Storti; Michel Barrois; Anne-Paule Gimenez-Roqueplo; Michel Leporrier; Nicole Casadevall; Olivier Hermine; Jean-Jacques Kiladjian; André Baruchel; Fadi Fakhoury; Brigitte Bressac-de Paillerets; Jean Feunteun; Nathalie Mazure; Jacques Pouysségur; Roland H Wenger; Stéphane Richard; Betty Gardie
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

Review 2.  Proteomics of the Synapse--A Quantitative Approach to Neuronal Plasticity.

Authors:  Daniela C Dieterich; Michael R Kreutz
Journal:  Mol Cell Proteomics       Date:  2015-08-25       Impact factor: 5.911

3.  Insights into Cullin-RING E3 ubiquitin ligase recruitment: structure of the VHL-EloBC-Cul2 complex.

Authors:  Henry C Nguyen; Haitao Yang; Jennifer L Fribourgh; Leslie S Wolfe; Yong Xiong
Journal:  Structure       Date:  2015-02-05       Impact factor: 5.006

4.  Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family.

Authors:  Ping Yuan; Qipeng Sun; Hao Liang; Wenjun Wang; Ling Li; Ye Wang; Huan Deng; Luhua Lai; Xiaoli Chen; Xiangfu Zhou
Journal:  Cancer Biol Ther       Date:  2016-04-08       Impact factor: 4.742

5.  A rare cause of hypertension in an 11-year-old boy: Answers.

Authors:  Abir Boussetta; Manel Jellouli; Rim Meddeb; Ridha Mrad; Riadh Jouini; Amina Karray; Said Jlidi; Tahar Gargah
Journal:  Pediatr Nephrol       Date:  2021-01-07       Impact factor: 3.714

Review 6.  Genetic predisposition to kidney cancer.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

Review 7.  Edgotype: a fundamental link between genotype and phenotype.

Authors:  Nidhi Sahni; Song Yi; Quan Zhong; Noor Jailkhani; Benoit Charloteaux; Michael E Cusick; Marc Vidal
Journal:  Curr Opin Genet Dev       Date:  2013-11-26       Impact factor: 5.578

8.  A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts.

Authors:  S Cingoz; R B van der Luijt; E Kurt; M Apaydin; I Akkol; Mihriban Heval Ozgen
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

9.  Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark.

Authors:  Marie Louise Mølgaard Binderup; Michael Galanakis; Esben Budtz-Jørgensen; Michael Kosteljanetz; Marie Luise Bisgaard
Journal:  Eur J Hum Genet       Date:  2016-12-14       Impact factor: 4.246

10.  The VHL-dependent regulation of microRNAs in renal cancer.

Authors:  Calida S Neal; Michael Z Michael; Lesley H Rawlings; Mark B Van der Hoek; Jonathan M Gleadle
Journal:  BMC Med       Date:  2010-10-21       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.